Please ensure Javascript is enabled for purposes of website accessibility

How the Presidential Election Could Impact Cannabis Stocks

Few sectors are as affected by politics as cannabis, and the upcoming presidential election could have significant implications for cannabis stocks.

Voting Booth

Despite the finalization of the respective tickets and polling that anticipates a competitive election, cannabis investors have been entirely ignoring the impending presidential election.

The sector, as measured by the AdvisorShares Pure U.S. Cannabis ETF (MSOS), has declined 7% since a Fox News poll showed Kamala Harris had surpassed Donald Trump in key swing states on July 29.

Bad move, cannabis investors.

Harris is both a better cannabis advocate than President Joe Biden and would be more favorable to the sector than Trump.

So let’s consider the investing implications of this (ultimately) political question.

Harris vs. Trump on Cannabis

While Harris supports full legalization, Trump does not. Indeed, he literally calls for the death penalty for drug dealers. His logic is that a similar policy in China explains lower levels of drug abuse there.

Of course, Trump is predominantly referring to more dangerous drugs like fentanyl. But he’s never been a big fan of cannabis reform. He believes cannabis use causes lasting cognitive impairment. He thinks state-level legalization has created “big problems.” And Trump suggests there may be a link between “genetically engineered” cannabis and mass shootings.

On the other hand, Trump is not entirely negative for the sector. He supports legalization of medical cannabis. He thinks cannabis policy should be left to the states, which implies a green light for further state-level legalization. When he was president, Trump declined to crack down on cannabis, even after his Attorney General Jeff Sessions rescinded the Obama-era “hands off” policy on enforcement of federal cannabis laws.

But if the Biden administration fails to reschedule cannabis, don’t expect any progress under a Trump presidency. In rescheduling, cannabis would move to Schedule III from Schedule I under the Controlled Substances Act. The change would help cannabis companies by neutralizing the impact of an Internal Revenue Service provision (Rule 280E) which bars the deduction of operating expenses against revenue from the sale of Schedule I substances like cannabis.

Trump won’t champion the issue. In contrast, Harris strongly supports rescheduling and she has asked the Drug Enforcement Administration (DEA) to move forward with it “as quickly as possible.”

As a Senator, Harris sponsored a legalization bill called the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act. “Times have changed. Marijuana should not be a crime,” she said at the time. She also co-sponsored the Secure and Fair Enforcement (SAFE) Banking Act, which would allow banks to serve cannabis companies.

Harris in Contrast to Biden on Reform

Biden opposes recreational-use legalization. In contrast, Harris backs full federal legalization of cannabis. That’s obviously a huge improvement for the sector.

Biden also has a history of anti-cannabis views. As chair of the Judiciary Committee years ago, he helped shape drug policy that stigmatized cannabis. He has described cannabis as a gateway drug that leads people to use more dangerous drugs, whereas Harris refutes this view. In short, Biden was out of step with the majority of voters who favor recreational-use legalization.

Harris is also better for the sector because according to recent polls, she stands a better chance than Biden of beating Trump.

Walz Supports Cannabis Reform

Minnesota Gov. Tim Walz (D) aggressively campaigned for rec-use legalization as governor of Minnesota, and eventually signed a legalization bill in 2023. He also signed a bill that lets hemp businesses market cannabis drinks and food containing cannabinoids. And he approved legislation to decriminalize drug paraphernalia.

In the U.S. House of Representatives, Walz supported a version of a banking reform bill that allows banks to serve cannabis companies. He also backed bills supporting medical cannabis research for veterans, the hemp industry, and a ban on federal interference with state-level legalization.

In contrast, Trump’s running mate Sen. JD Vance (R-OH) opposes recreational-use legalization. He has also voted against a cannabis banking reform bill called the Secure and Fair Enforcement Regulation (SAFER) Banking Act which would allow banks to serve cannabis companies.

A Harris Victory Would Imply Other Wins for Cannabis

Several states have initiatives on the ballot this November that would allow voters to approve major cannabis reform. The big one is Florida, where voters get to decide whether to make recreational use legal. Polls showing that Harris may win suggest big turnouts in favor of pro-cannabis initiatives like the one in Florida.

Besides Florida, recreational-use legalization will likely be on the ballot in North Dakota. Medical use legalization will likely be on the ballot in Nebraska. Expansion of medical use will be on the ballot in Arkansas. And cannabis decriminalization will be on the ballot in several local elections in Texas.

The bottom line: A lot can happen between now and November. But if Harris continues to poll well against Trump, I expect cannabis investors to catch on and cannabis stocks to catch a bid – which suggests they are a buy in the steep sell-off since May.

Michael Brush is an award-winning Manhattan-based financial writer who writes a stock market column for MarketWatch. He is editor of Brush Up on Stocks, an investment newsletter. Brush previously covered the stock market, business and economics for the New York Times, the Economist Group, MSN Money, and Money magazine.